Back

Implementation of the european society cardiac amyloidosis diagnostic algorithm for transthyretin amyloid cardiomyopathy: First real-world data on a heart failure unit in Colombia.

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - heart failure with reduced ejection fraction (HFrEF) 1 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Ms Astrid Rodriguez

Fundacion Santa Fe de Bogota, Bogota (Colombia)

5 More presentations in this session

Presentation thumbnail
Impact on atrial remodeling of dapagliflozin in patients with heart failure: MODA study. rational and design.
Mr A. Riquelme Perez (El Palmar, Murcia, ES)
Abstract Slides
Presentation thumbnail
CPET parameters correlation to Exercise Echocardiographic characteristics in patients with diastolic dysfunction
Doctor B. Son (Daegu, KR)
Abstract Slides
Presentation thumbnail
Utility of left ventricular isovolumic contraction velocity in patients with heart failure with preserved ejection fraction
Doctor T. Kawata (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Impact on atrial remodeling of dapagliflozin in patients with heart failure (MODA TRIAL): baseline echo characteristics according to LVEF phenotypes
Mr A. Riquelme Perez (El Palmar, Murcia, ES)
Abstract Slides
Presentation thumbnail
Impact on atrial remodeling of dapagliflozin in patients with heart failure (MODA TRIAL): baseline clinical characteristics
Mr A. Riquelme Perez (El Palmar, Murcia, ES)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - heart failure with reduced ejection fraction (HFrEF) 1

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources